ATNF: 180 Life Sciences Corp. Stock

by  •  • Comments Off on ATNF: 180 Life Sciences Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.21
Enterprise Value ($M) -0.22
Book Value ($M) 9.25
Book Value / Share 1.78
Price / Book 0.45
NCAV ($M) 1.63
NCAV / Share 0.31
Price / NCAV 2.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) -1.79
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.47
Current Ratio 1.47

Balance Sheet (mrq) ($M)
Current Assets 5.14
Assets 12.76
Liabilities 3.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -6.32
Net Income -6.17
Earnings Per Share Diluted n/a
Earnings Per Share Nonrecurring Common Control Intra Entity Transactions Description n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -1.48
Cash from Investing 0.00
Cash from Financing 4.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G Amtrust Financial Services, Inc. 9.80
8 days ago 13D/A Elray Resources, Inc. 52.80
02-25 13D Jordan Blair 10.50
01-10 13D Goodman Anthony Brian 57.60
01-03 13G Intracoastal Capital, Llc 4.99
11-14 13G/A Armistice Capital, Llc 4.99 -95.15

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 14,053 20,399 68.89
2025-04-16 23,167 72,745 31.85
2025-04-15 17,516 39,956 43.84
2025-04-14 3,342 38,704 8.63

(click for more detail)

Similar Companies
ASNS – Actelis Networks, Inc. ASRT – Assertio Holdings, Inc.
ATHA – Athira Pharma, Inc. ATOS – Atossa Therapeutics, Inc.
ATYR – aTyr Pharma, Inc.


Financial data and stock pages provided by
Fintel.io